Evidence map›Paper›PMID 33921724›Full record

ReviewPharmaceuticals (Basel, Switzerland)2021

Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview.

Tapan Behl, Gabriele Rocchetti, Swati Chadha, Gokhan Zengin, Simona Bungau, Arun Kumar, Vineet Mehta, Md Sahab Uddin, Gaurav Khullar, Dhruv Setia and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Antiviral and Immune Enhancement Effect ofMolecules (Basel, Switzerland) · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Antiviral Activity of Water-Alcoholic Extract ofInternational journal of molecular sciences · 2025
    Article
  16. Article
  17. Green Synthesis and Characterization of Silver Nanoparticles UsingInternational journal of nanomedicine · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 6 countries.

Tapan BehlChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Gabriele RocchettiDepartment for Sustainable Food Process, University Cattolica del Sacro Cuore, 29122 Piacenza, Italy.ORCID 0000-0003-3488-4513
Swati ChadhaChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Gokhan ZenginDepartment of Biology, Faculty of Science, Selcuk University Campus, Konya 42130, Turkey.ORCID 0000-0001-6548-7823
Simona BungauDepartment of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.ORCID 0000-0003-3236-1292
Arun KumarChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Vineet MehtaDepartment of Pharmacology, Government College of Pharmacy, Rohru, Distt. Shimla, Himachal Pradesh 171207, India.
Md Sahab UddinDepartment of Pharmacy, Southeast University, Dhaka 1213, Bangladesh.ORCID 0000-0002-0805-7840
Gaurav KhullarChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Dhruv SetiaChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Sandeep AroraChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Kouadio Ibrahime SinanDepartment of Biology, Faculty of Science, Selcuk University Campus, Konya 42130, Turkey.
Gunes AkDepartment of Biology, Faculty of Science, Selcuk University Campus, Konya 42130, Turkey.
Predrag PutnikDepartment of Food Technology, University North, 48000 Koprivnica, Croatia.ORCID 0000-0003-0342-6114
Monica GalloDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via Pansini, 5, 80131 Naples, Italy.ORCID 0000-0001-6281-426X
Domenico MontesanoDepartment of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-8857-2091
Chitkara University · INSelçuk University · TRUniversity of Naples Federico II · ITGovernment of Himachal Pradesh · INSoutheast University · BDUniversità Cattolica del Sacro Cuore · ITUniversity North · HRUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, the leading causes of mortality and morbidity worldwide include viral infections, such as Ebola, influenza virus, acquired immunodeficiency syndrome (AIDS), severe acute respiratory syndrome (SARS) and recently COVID-19 disease, caused by the SARS-CoV-2 virus. Currently, we can count on a narrow range of antiviral drugs, especially older generation ones like ribavirin and interferon which are effective against viruses in vitro but can often be ineffective in patients. In addition to these, we have antiviral agents for the treatment of herpes virus, influenza virus, HIV and hepatitis virus. Recently, drugs used in the past especially against ebolavirus, such as remdesivir and favipiravir, have been considered for the treatment of COVID-19 disease. However, even if these drugs represent important tools against viral diseases, they are certainly not sufficient to defend us from the multitude of viruses present in the environment. This represents a huge problem, especially considering the unprecedented global threat due to the advancement of COVID-19, which represents a potential risk to the health and life of millions of people. The demand, therefore, for new and effective antiviral drugs is very high. This review focuses on three fundamental points: (1) presents the main threats to human health, reviewing the most widespread viral diseases in the world, thus describing the scenario caused by the disease in question each time and evaluating the specific therapeutic remedies currently available. (2) It comprehensively describes main phytochemical classes, in particular from plant foods, with proven antiviral activities, the viruses potentially treated with the described phytochemicals. (3) Consideration of the various applications of drug delivery systems in order to improve the bioavailability of these compounds or extracts. A PRISMA flow diagram was used for the inclusion of the works. Taking into consideration the recent dramatic events caused by COVID-19 pandemic, the cry of alarm that denounces critical need for new antiviral drugs is extremely strong. For these reasons, a continuous systematic exploration of plant foods and their phytochemicals is necessary for the development of new antiviral agents capable of saving lives and improving their well-being.

Indexed as

antiviral agentsdelivery technologiesphytochemicalsplant foodsreplicationviruses

Identifiers

PMID33921724
PMCPMC8073840
OpenAlexW3155202591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.